PFPT
AZN icon

Pinnacle Financial Partners (Tennessee)’s AstraZeneca AZN Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$443K Buy
2,886
+826
+40% +$125K 0.01% 348
2025
Q2 		$288K Sell
2,060
-137
-6% -$19.2K 0.01% 397
2025
Q1 		$323K Buy
2,197
+236
+12% +$34.1K 0.01% 374
2024
Q4 		$257K Buy
1,961
+7
+0.4% +$980 0.01% 398
2024
Q3 		$304K Buy
1,954
+476
+32% +$76.8K 0.01% 375
2024
Q2 		$230K Sell
1,478
-24
-2% -$3.61K ﹤0.01% 405
2024
Q1 		$203K Sell
1,502
-221
-13% -$29.3K ﹤0.01% 430
2023
Q4 		$232K Buy
+1,723
New +$224K 0.01% 392
2017
Q3 		– Sell
-4,617
Closed -$314K – 288
2017
Q2 		$314K Buy
4,617
+115
+3% +$7.51K 0.04% 234
2017
Q1 		$280K Buy
+4,502
New +$262K 0.06% 208
2016
Q4 		– Sell
-3,349
Closed -$202K – 237
2016
Q3 		$202K Hold
3,349
– – 0.05% 263
2016
Q2 		$202K Sell
3,349
-9,442
-74% -$548K 0.05% 254
2016
Q1 		$720K Sell
12,791
-4,804
-27% -$289K 0.18% 136
2015
Q4 		$1.2M Sell
17,595
-1,172
-6% -$76.8K 0.37% 81
2015
Q3 		$1.2M Buy
18,767
+137
+0.7% +$9.01K 0.38% 81
2015
Q2 		$1.19M Buy
18,630
+668
+4% +$45.7K 0.38% 81
2015
Q1 		$1.23M Buy
17,962
+2,087
+13% +$145K 0.41% 79
2014
Q4 		$1.12M Buy
15,875
+159
+1% +$11.4K 0.39% 81
2014
Q3 		$1.12M Buy
15,716
+639
+4% +$46.8K 0.43% 73
2014
Q2 		$1.12M Sell
15,077
-409
-3% -$29.6K 0.45% 71
2014
Q1 		$1M Buy
15,486
+1,013
+7% +$65.4K 0.45% 75
2013
Q4 		$859K Buy
14,473
+2,080
+17% +$113K 0.39% 81
2013
Q3 		$644K Buy
+12,393
New +$622K 0.32% 80

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s AZN Position: Q3 2025 in Review

Pinnacle Financial Partners (Tennessee) increased its AstraZeneca (AZN) stake by 40% in Q3 2025, buying an estimated $125K and bringing the position to 2,886 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #348.

Pinnacle Financial Partners (Tennessee) first reported a position in AZN in Q3 2013 and has held it in 23 quarters since. The position peaked at $1.23M in Q1 2015. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Pinnacle Financial Partners (Tennessee) held 2,886 shares of AstraZeneca worth $443K as of Q3 2025.
  • Pinnacle Financial Partners (Tennessee) bought 826 AstraZeneca shares in Q3 2025, an estimated $125K.
  • AstraZeneca made up 0.01% of Pinnacle Financial Partners (Tennessee)'s portfolio in Q3 2025, its #348 holding.
  • Pinnacle Financial Partners (Tennessee) first reported a position in AstraZeneca in Q3 2013 and has held it in 23 quarters since.
  • Pinnacle Financial Partners (Tennessee)'s AstraZeneca position peaked at $1.23M in Q1 2015.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2025, filed 28 Oct 2025.